Instil Bio Inc (TIL)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$7.58-1.04%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · TIL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | — | — | — | — | 0.0 | 0.1 |
| Operating Expenses & Income | |||||||
| R&D Expenses | — | — | — | 39.6 | 141.1 | 107.3 | 19.4 |
| Operating Income | (37.2) | (78.6) | (73.5) | (159.2) | (226.5) | (155.6) | (33.6) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 5.8 | 9.0 | 5.2 | 1.9 | 0.0 | — |
| Other Non-Operating Income / Expenses | — | 0.2 | (2.9) | (0.6) | (0.6) | (1.3) | (3.9) |
| EBT, Incl. Unusual Items | — | (71.4) | (74.1) | (156.1) | (225.3) | (156.8) | (37.6) |
| Income Tax Expense | — | — | — | 0.0 | (2.1) | 0.0 | 0.2 |
| Net Income | |||||||
| Net Income | (30.3) | (71.4) | (74.1) | (156.1) | (223.2) | (156.8) | (37.7) |
| Per Share | |||||||
| Basic EPS | (4.46) | (10.70) | (11.39) | (24.00) | (34.46) | (1.48) | (2.36) |
| Diluted EPS | (4.46) | (10.70) | (11.39) | (24.00) | (34.46) | (1.48) | (2.36) |
| Basic Weighted Avg Shares | 6.8 | 6.7 | 6.5 | 6.5 | 6.5 | 106.0 | 16.0 |
| Diluted Weighted Avg Shares | 6.8 | 6.7 | 6.5 | 6.5 | 6.5 | 106.0 | 16.0 |
| Supplemental | |||||||
| EBITDA | — | (78.0) | (69.9) | (154.4) | (220.5) | (152.8) | (33.4) |
| EBIT | (37.2) | (78.6) | (73.5) | (159.2) | (226.5) | (155.6) | (33.6) |
| Effective Tax Rate | — | — | — | 0.0% | 0.9% | -0.0% | -0.4% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.